Human U87 glioblastoma cells with stemness features display enhanced sensitivity to natural killer cell cytotoxicity through altered expression of NKG2D ligand-Reference-Cited by-同舟云学术

Human U87 glioblastoma cells with stemness features display enhanced sensitivity to natural killer cell cytotoxicity through altered expression of NKG2D ligand

Published:2017-02-10 Issue:1 Volume:17 Page:
ISSN:1475-2867
Container-title:Cancer Cell International
language:en
Short-container-title:Cancer Cell Int

Author:

Oh Se-Jeong,Yang Jung-In,Kim Ok,Ahn Eun-Jung,Kang Woo Dae,Lee Jae-Hyuk,Moon Kyung-Sub,Lee Kyung-Hwa,Cho Duck

Funder

Chonnam National University Hospital (KR)

National Research Foundation of Korea

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s12935-017-0397-7.pdf

Reference22 articles.

1. Ostrom QT, Bauchet L, Davis FG, Deltour I, Fisher JL, Langer CE, Pekmezci M, Schwartzbaum JA, Turner MC, Walsh KM, et al. The epidemiology of glioma in adults: a “state of the science” review. Neuro Oncol. 2014;16(7):896–913.

2. Liebelt BD, Shingu T, Zhou X, Ren J, Shin SA, Hu J. Glioma stem cells: signaling, microenvironment, and therapy. Stem Cells Int. 2016;2016:7849890.

3. Cho D, Kim SK, Carson WE 3rd. NK cell-based immunotherapy for treating cancer: will it be promising? Korean J Hematol. 2011;46(1):3–5.

4. Fujisaki H, Kakuda H, Shimasaki N, Imai C, Ma J, Lockey T, Eldridge P, Leung WH, Campana D. Expansion of highly cytotoxic human natural killer cells for cancer cell therapy. Cancer Res. 2009;69(9):4010–7.

5. Avril T, Vauleon E, Hamlat A, Saikali S, Etcheverry A, Delmas C, Diabira S, Mosser J, Quillien V. Human glioblastoma stem-like cells are more sensitive to allogeneic NK and T cell-mediated killing compared with serum-cultured glioblastoma cells. Brain Pathol. 2012;22(2):159–74.

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interaction of NF-κB and FOSL1 drives glioma stemness;Cellular and Molecular Life Sciences;2024-06-10

2. Targeting NKG2D ligands in glioblastoma with a bispecific T-cell engager is augmented with conventional therapy and enhances oncolytic virotherapy of glioma stem-like cells;Journal for ImmunoTherapy of Cancer;2024-05

3. Aryl-isoquinoline as a Potential Scaffold for Novel Antitumor Agents Against Glioblastoma Cells;Letters in Drug Design & Discovery;2024-04

4. Cancer stem cells: a target for overcoming therapeutic resistance and relapse;Cancer Biology & Medicine;2024-02-05

5. Evaluation of Temozolomide and Fingolimod Treatments in Glioblastoma Preclinical Models;Cancers;2023-09-08